Particle.news

Download on the App Store

Estrogen Derivatives Inhibit Ferroptosis, Explaining Lower Kidney Injury Risk in Women

Estrogen metabolites trigger radical-scavenging defenses against lipid peroxidation, suggesting potential for targeted kidney therapies

Content cover image
Image
Image
Image

Overview

  • A Nature study by Tonnus et al. demonstrates that oestradiol and hydroxylated metabolites block ferroptosis in renal cells.
  • The researchers identified genomic and non-genomic pathways, including the upregulation of hydropersulfides and preservation of ether lipids, as key protective mechanisms.
  • Female mice showed resistance to acute kidney injury and suppression of renal tubular ferroptosis propagation in animal experiments.
  • Tom Vanden Berghe’s Nature News & Views commentary describes the work as a milestone that broadens the physiological relevance of ferroptosis beyond cancer and neurodegeneration.
  • Experts suggest exploring estrogenic metabolites or ferroptosis inhibitors as potential therapies for AKI, although clinical translation remains at an early stage.